Free Republic

Not to be biased, but I felt I needed to share some first hand knowledge from the last few days regarding the home tests. Two of my daughters are nurses in a major hospital. Both along with three other nurses they work closely with, and two of their children came down with the dreaded "symptoms". So they all took home tests that showed positive for Covid. As a work and school requirement for the kids, they all had to take the longer term 48 hr test before they could return to work and school. All tested negative with the second...

The covid-19 response plan President Biden unveiled Thursday envisions a sweeping expansion of coronavirus testing, aiming to make quick-turnaround test kits cheaper and more accessible than ever as the country tries to quell the wave of infections driven by the delta variant. Leaning on test manufacturers to ramp up production, the administration wants to send hundreds of millions of rapid and at-home tests to local clinics, schools and other establishments nationwide in hopes of making it easier for people to catch infections and contain outbreaks early. Major retailers have also joined the push, offering at-home tests to consumers at less...

The Food & Drug Administration issued a class I recall for a defective COVID rapid test that had been the “benchmark” for testing in the United States. It continues an alarming trend of problems with COVID tests in the United States. “The FDA has classified the recall of this test as a Class I recall, the most serious type of recall,” the government agency said. “The FDA also has issued a warning letter to Innova Medical Group, Inc.” Innova describes itself as “the world’s largest manufacturer of rapid antigen tests and leader in COVID-19 testing solutions globally.” The FDA states...

Editor’s note: This post has been updated with new information. Almost a year into the COVID-19 pandemic, infections are still skyrocketing. With air passenger traffic at 34% of what it was pre-pandemic, and travelers hungry to get back on the road and into the skies, the scramble to find a solution is on. For more TPG news delivered each morning to your inbox, sign up for our daily newsletter. Vaccines have arrived, but mass production and broad availability could still be months away. As the industry continues to explore ways to jumpstart travel, some airports and airlines have a potential...

Elon Musk @elonmusk Something extremely bogus is going on. Was tested for covid four times today. Two tests came back negative, two came back positive. Same machine, same test, same nurse. Rapid antigen test from BD. 9:47 PM · Nov 12, 2020·Twitter for iPhone

“Something extremely bogus is going on. Was tested for covid four times today. Two tests came back negative, two came back positive,” Musk said on Twitter. “Same machine, same test, same nurse. Rapid antigen test from BD.”

A team of scientists in India has developed an inexpensive paper-based test for coronavirus that could give fast results similar to a pregnancy test. The BBC's Soutik Biswas and Krutika Pathi unpack how it works. The test, named after a famous Indian fictional detective, is based on a gene-editing technology called Crispr. Scientists estimate that the kit - called Feluda - would return results in under an hour and cost 500 rupees (about $6.75; £5.25). Feluda will be made by a leading Indian conglomerate, Tata, and could be the world's first paper-based Covid-19 test available in the market. "This is...

LIVE: President Trump URGENT News Conference from the White House

Today, the Trump Administration is pleased to announce the purchase and production of 150 million rapid tests to be distributed across the country. In March, President Donald J. Trump called for the development of a low cost, reliable point-of-care test. To deliver on this promise, the Administration has partnered with Abbott Laboratories to produce inexpensive and easy-to-use Abbott BinaxNOW tests. This is a major development that will help save more lives by further protecting America’s most vulnerable and allow our country to remain open, get Americans back to work, and get kids back to school. Under President Trump’s leadership, the...

In less than a month, Abbott Laboratories has shipped 566,000 of its highly touted “rapid” molecular tests for the Coronavirus strain COVID-19 to all 50 U.S. states. The effort to get the ID NOW COVID-19 test to doctor’s offices, urgent care centers and temporary testing sites like drive-thru parking lot locations is a snapshot into the massive diagnostic effort under way in the U.S. Abbott’s ID NOW COVID-19 test can deliver “positive results in as little as five minutes and negative results in 13 minutes.” The test, hailed by Donald Trump from the White House and praised by commercial companies...